glp-1 reconstitution calculator Peptide Journal Log – Tracker Form Printable + BONUS Peptide GLP1 Dose Calculator | Albany

Phenolic substances also include a group of compounds called flavonoids

Storage duration critically impacts effectiveness - reconstituted GHK-Cu lasts only 21-28 days refrigerated due to copper oxidation concerns (shorter than most peptides), requiring strategic reconstitution of amounts usable within this window rather than preparing entire vials at once

While the ongoing SURPASS clinical trial aims to elucidate the mechanistic underpinnings of the drug and the best dosages for treating patients of varying BMIs, its benefits cannot be understated

PPMS Phase 3 initiation expected 2026)North AmericaEurope IMU-856IMU-856 / SIRT6 modulator / Oral small molecule / Gastrointestinal diseasesCeliac diseasePhase 1bCompleted (positive proof-of-concept)Global IMU-381IMU-381 / Nurr1 / Oral small molecule / Autoimmune diseasesNeurologic, gastrointestinal and other autoimmune diseasesPreclinicalPreclinical 3assets 3assets RilonaceptARCALYST 3assets tarcocimab tedromerZenkuda / VEGF / Antibody Biopolymer Conjugate (ABC) / OphthalmologyWet Age-Related Macular Degeneration (wet AMD)Diabetic RetinopathyRetinal Vein Occlusion (RVO) KSI-501KSI-501 / IL-6 / VEGF / Bispecific Antibody Biopolymer Conjugate (ABC) / OphthalmologyWet Age-Related Macular Degeneration (wet AMD)Diabetic Macular Edema (DME) KSI-101KSI-101 / IL-6 / VEGF / Bispecific Protein / OphthalmologyMacular Edema Secondary to Inflammation (MESI) 3assets mivocabtagene autoleucelKYV-101 / CD19 / Autologous CAR T-cell therapy / Autoimmune DiseasesStiff Person Syndrome (SPS)Phase 2Completed (Preparing BLA)USGeneralized Myasthenia Gravis (gMG)Phase 3OngoingUSLupus Nephritis (LN)Phase 1/2OngoingUSGermany KYV-102KYV-102 / CD19 / Autologous CAR T-cell therapy / Autoimmune DiseasesAutoimmune DiseasesPhase 1IND ActiveUS KYV-201KYV-201 / CD19 / Allogeneic CAR T-cell therapy / Autoimmune DiseasesAutoimmune DiseasesPreclinicalActiveUS 3assets SotagliflozinINPEFA / ZYNQUISTA / SGLT1 / SGLT2 / Small Molecule / CardiometabolicHeart FailureApprovedactiveUnited StatesHypertrophic Cardiomyopathy (HCM)Phase 3activeGlobalType 1 Diabetes (T1D)RegistrationactiveUnited States PilavapadinLX9211 / AAK1 / Small Molecule / Pain / NeurologyDiabetic Peripheral Neuropathic Pain (DPNP)Phase 2bactiveUnited StatesPostherpetic Neuralgia (PHN)Phase 2inactiveUnited States LX9851LX9851 / ACSL5 / Small Molecule / MetabolismObesity / Weight ManagementPhase 1activeGlobal 3assets 3assets ZidesamtinibNVL-520 NeladalkibNVL-655 3assets LicaminlimabOCS-02 PrivosegtorOCS-05 3assets 3assets 3assets 3assets D-PLEX100D-PLEX100 / Bacterial Ribosome / Small Molecule Formulation / Infectious Diseases / Surgical Site CarePrevention of surgical site infections (SSIs) following abdominal colorectal surgeryPhase 3OngoingUnited StatesEuropeIsrael PP03APP03A / GLP-1 Receptor / Peptide Formulation / Metabolic DiseaseObesity and Type 2 DiabetesPreclinicalOngoing PP04APP04A / OncoPLEX / STING / Small Molecule Formulation / OncologySolid TumorsPreclinicalOngoing 3assets QRX003QRX003 / Serine protease inhibitor / Small molecule / DermatologyNetherton SyndromePhase 3OngoingUnited StatesEuropeMiddle EastPeeling Skin SyndromePhase 2OngoingNew Zealand Topical rapamycinQRX009 / mTOR / Small molecule / DermatologyMicrocystic Lymphatic MalformationsPreclinicalOngoingGlobalVenous MalformationsPreclinicalOngoingGlobalAngiofibromaPreclinicalOngoingGlobal QRX008QRX008 / VLA-4 / VCAM-1 inhibitor / Small molecule / DermatologySclerodermaPreclinicalOngoingGlobal 3assets RAP-219RAP-219 / TARP8 AMPAR / Small molecule / Neurology/PsychiatryFocal onset seizuresPrimary generalized tonic-clonic seizuresBipolar mania 64 nAChR Agonist64 nAChR / Small molecule / NeurologyChronic painMigraine 910 nAChR Modulator910 nAChR / Small molecule / Hearing/VestibularHearing disordersVestibular disorders 3assets PC111PC111 / sFasL (soluble Fas Ligand) / Monoclonal Antibody / Immunology / DermatologyPemphigusPreclinicalActiveGlobalStevens-Johnson syndrome / toxic epidermal necrolysis (SJS/TEN)PreclinicalActiveGlobal Intradermal IL-17A/F NanoAbIL-17A / IL-17F / VHH Antibody Fragment (NanoAb) / Immunology / DermatologyMild-to-moderate plaque psoriasisPreclinicalActiveGlobal Systemic Bi-Specific IL-17 NanoAbIL-17A / IL-17F and secondary proprietary target / Bi-specific VHH Antibody Fragment (NanoAb) / Immunology / DermatologyModerate-to-severe plaque psoriasisPreclinicalActiveGlobalPsoriatic arthritisPreclinicalActiveGlobal 3assets DenifanstatASC40 / FASN / Small molecule / Metabolic disease, Dermatology, OncologyMASH (F2/F3)Phase 3ActiveModerate to severe acnePhase 3ActiveRecurrent glioblastoma (GBM)Phase 3Active TVB-3567FASN / Small molecule / Dermatology, OncologyAcnePhase 1ActiveSolid tumorsPreclinicalActive FASNi TopicalFASN / Small molecule / DermatologyAcnePreclinicalActive 3assets 3assets lotilaner ophthalmic solution 0.25%TP-03 / XDEMVY / Small molecule / Eye CareDemodex blepharitisMeibomian Gland Disease lotilaner ophthalmic gelTP-04 / Small molecule / Dermatology / Eye CareRosaceaOcular rosacea lotilaner oral tabletTP-05 / Small molecule / Infectious Disease PreventionLyme disease preventionCommunity reduction of malaria 3assets TX45TX-000045 / RXFP1 / Fc-relaxin fusion protein / CardiopulmonaryPH-HFpEF (Group 2 Pulmonary Hypertension)PH-HFrEF (Group 2 Pulmonary Hypertension)PH-ILD (Group 3 Pulmonary Hypertension) TX2100TX002100 / GPCR / Biotherapeutic / GPCR Antagonist / Hematology / Rare DiseasesHereditary Hemorrhagic Telangiectasia (HHT) Fibrosis ProgramGPCR / Bispecific GPCR Antagonist / FibrosisFibrosis 3assets ublituximabTG-1101 / BRIUMVI / CD20 / Monoclonal Antibody / Autoimmune DiseasesRelapsing Multiple Sclerosis (RMS) ublituximab subcutaneousCD20 / Monoclonal Antibody / Autoimmune DiseasesRelapsing Multiple Sclerosis (RMS) azercabtagene zapreleucelazer-cel / CD19 / Allogeneic CAR-T Cell Therapy / Autoimmune DiseasesProgressive Multiple Sclerosis (PMS)Autoimmune Diseases 3assets Intranasal ForalumabTZLS-401 / CD3 epsilon / Monoclonal Antibody / Neurology/ImmunologyNon-Active Secondary Progressive Multiple Sclerosis (SPMS)Multiple System Atrophy (MSA)Mild Alzheimer's Disease Anti IL-6R mAbTZLS-501 / IL-6R / Monoclonal Antibody / Immunology MilciclibTZLS-201 / CDKs / Small Molecule / OncologyNSCLC with pan KRAS-positive mutations 3assets TN-201TN-201 / MYBPC3 / AAV-based gene therapy / CardiovascularMYBPC3-associated Hypertrophic Cardiomyopathy (HCM) TN-401TN-401 / PKP2 / AAV9-based gene therapy / CardiovascularPKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) TN-301TN-301 / HDAC6 / Small Molecule / Cardiometabolic / NeuromuscularHeart Failure with preserved Ejection Fraction (HFpEF)Duchenne Muscular Dystrophy (DMD) 3assets sparsentanFILSPARI pegtibatinaseTVT-058 tioproninThiola / Thiola EC 3assets dabogratinibTYRA-300 / FGFR3 / Small molecule / Oncology / Skeletal DysplasiaMetastatic Urothelial Cancer (mUC)Non-Muscle Invasive Bladder Cancer (IR NMIBC)Achondroplasia TYRA-200TYRA-200 / FGFR1/2/3 / Small molecule / OncologyIntrahepatic CholangiocarcinomaAdvanced Solid Tumors TYRA-430TYRA-430 / FGFR4/3 / Small molecule / OncologyHepatocellular Carcinoma (HCC)Advanced Solid Tumors 3assets AtaciceptVT-001 / BAFF and APRIL / Recombinant Fusion Protein / Immunology / NephrologyIgA Nephropathy (IgAN)BLA SubmittedPriority Review (PDUFA July 2026)USGlobalLupus NephritisPhase 2OngoingGlobalFocal Segmental Glomerulosclerosis (FSGS)Phase 2OngoingGlobal MAU868MAU868 / BK Virus / Monoclonal Antibody / Infectious Disease / TransplantationBK Viremia in Kidney Transplant RecipientsPhase 2Evaluating for future developmentGlobal VT-109VT-109 / BAFF and APRIL / Fusion Protein / ImmunologyB Cell Mediated DiseasesPreclinicalActiveGlobal 3assets Avutometinib and DefactinibVS-6766 / VS-6063 / AVMAPKI FAKZYNJA CO-PACK / RAF/MEK and FAK / Small Molecule / OncologyKRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)ApprovedActiveUnited StatesRecurrent low-grade serous ovarian cancer (LGSOC)Phase 3ActiveGlobalMetastatic Pancreatic Cancer (PDAC)Phase 2ActiveGlobal AvutometinibVS-6766 / RAF/MEK / Small Molecule / OncologyBRAF, KRAS and NRAS-Mutant Solid TumorsPhase 1ActiveGlobal VS-7375GFH375 / KRAS G12D / Small Molecule / OncologyKRAS G12D-Mutated Solid TumorsPhase 1/Phase 2ActiveUnited StatesChina 3assets tibulizumabZB-106 / IL-17A and BAFF / Bispecific dual-antagonist antibody / Autoimmune and Inflammatory DiseasesHidradenitis suppurativaSystemic sclerosis crebankitugZB-168 / IL-7R / Monoclonal antibody / Autoimmune and Inflammatory DiseasesAutoimmune and inflammatory conditions torudokimabZB-880 / IL-33 / Monoclonal antibody / Autoimmune and Inflammatory DiseasesAutoimmune and inflammatory conditions 2assets 2assets ImdusiranAB-729

Chew well before swallowing